Log in
Enquire now
‌

US Patent 8188110 Morphinan compounds

Patent 8188110 was granted and assigned to Concert Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Concert Pharmaceuticals
Concert Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8188110
Date of Patent
May 29, 2012
Patent Application Number
13118912
Date Filed
May 31, 2011
Patent Citations Received
‌
US Patent 12109178 Bupropion as a modulator of drug activity
0
‌
US Patent 11779579 Bupropion as a modulator of drug activity
‌
US Patent 11969421 Bupropion as a modulator of drug activity
0
Patent Primary Examiner
‌
Charanjit Aulakh
Patent abstract

This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σ1 receptor agonist that also has NMDA antagonist activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8188110 Morphinan compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.